Research and Development

When Peter Gassner, CEO and founder of Veeva, provided the keynote speech at the company’s European Commercial & Medical Summit, …

When PD-1/L1 treatments first came on the market, there was a race to snaffle as many indications as possible for …

GlaxoSmithKline’s Consumer Healthcare business has revealed that Filippo Lanzi is to take over as Regional Head of Asia Pacific, overseeing …

Hikma Pharmaceuticals has announced that Surendera Tyagi is being brought in to join the company as Group Chief Scientific Officer …

Novartis has lifted the curtain on new data comparing the efficacy of Cosentyx (secukinumab) to Janssen’s Stelara (ustekinumab) in achieving …

Real world evidence is high on the agenda at many conferences, as people mull over the possibilities that it may …

The Xmas break is now a distant memory as we move further into January, and with another Friday comes another …

The BRCA1 and BRCA2 genes are known to significantly increase the chances of a woman developing cancer and it was …

It’s been a terrible week for Alzheimer’s disease research, after Pfizer shuttered its neuroscience unit and

Novartis has been looking to find someone to fill the shoes of Bruno Strigini since it was revealed that he …

AstraZeneca and its biologics R&D unit MedImmune have announced that their drug Fasenra (benralizumab) has received approval from the European …

Dr Aidan Murphy has been named by Ipsen’s new Executive Vice President, Technical Operations, succeeding Jonathan Barnsley who retired at …

Danish pharmaceutical firm Lundbeck has signed a separate licensing and research collaboration agreement with Tennessee’s Vanderbilt University to develop a …

It’s been a gloomy period for research into Alzheimer’s disease treatments in the last week, Pfizer announced it would be …

Bayer and Johnson & Johnson have managed to avert a payout of $27.8 million after a Pennsylvania state court judge …